Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Hospital Acquired Urinary Tract Infection Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Hospital Acquired Urinary Tract Infection Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Microbial Testing Instruments
      • 1.3.3 Reagents and Consumables
      • 1.3.4 Infection Prevention and Surveillance Software
    • 1.4 Market Segment by Application
      • 1.4.1 Global Hospital Acquired Urinary Tract Infection Market Share by Application (2019-2025)
      • 1.4.2 Disease Testing
      • 1.4.3 Drug-resistance Testing
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Hospital Acquired Urinary Tract Infection Market Size
      • 2.1.1 Global Hospital Acquired Urinary Tract Infection Revenue 2014-2025
      • 2.1.2 Global Hospital Acquired Urinary Tract Infection Sales 2014-2025
    • 2.2 Hospital Acquired Urinary Tract Infection Growth Rate by Regions
      • 2.2.1 Global Hospital Acquired Urinary Tract Infection Sales by Regions 2014-2019
      • 2.2.2 Global Hospital Acquired Urinary Tract Infection Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Hospital Acquired Urinary Tract Infection Sales by Manufacturers
      • 3.1.1 Hospital Acquired Urinary Tract Infection Sales by Manufacturers 2014-2019
      • 3.1.2 Hospital Acquired Urinary Tract Infection Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Hospital Acquired Urinary Tract Infection Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hospital Acquired Urinary Tract Infection Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Hospital Acquired Urinary Tract Infection Market Concentration Ratio (CR5 and HHI)
    • 3.3 Hospital Acquired Urinary Tract Infection Price by Manufacturers
    • 3.4 Key Manufacturers Hospital Acquired Urinary Tract Infection Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Hospital Acquired Urinary Tract Infection Market
    • 3.6 Key Manufacturers Hospital Acquired Urinary Tract Infection Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Microbial Testing Instruments Sales and Revenue (2014-2019)
      • 4.1.2 Reagents and Consumables Sales and Revenue (2014-2019)
      • 4.1.3 Infection Prevention and Surveillance Software Sales and Revenue (2014-2019)
    • 4.2 Global Hospital Acquired Urinary Tract Infection Sales Market Share by Type
    • 4.3 Global Hospital Acquired Urinary Tract Infection Revenue Market Share by Type
    • 4.4 Hospital Acquired Urinary Tract Infection Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Hospital Acquired Urinary Tract Infection Sales by Application

    6 United States

    • 6.1 United States Hospital Acquired Urinary Tract Infection Breakdown Data by Company
    • 6.2 United States Hospital Acquired Urinary Tract Infection Breakdown Data by Type
    • 6.3 United States Hospital Acquired Urinary Tract Infection Breakdown Data by Application

    7 European Union

    • 7.1 European Union Hospital Acquired Urinary Tract Infection Breakdown Data by Company
    • 7.2 European Union Hospital Acquired Urinary Tract Infection Breakdown Data by Type
    • 7.3 European Union Hospital Acquired Urinary Tract Infection Breakdown Data by Application

    8 China

    • 8.1 China Hospital Acquired Urinary Tract Infection Breakdown Data by Company
    • 8.2 China Hospital Acquired Urinary Tract Infection Breakdown Data by Type
    • 8.3 China Hospital Acquired Urinary Tract Infection Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Hospital Acquired Urinary Tract Infection Breakdown Data by Company
    • 9.2 Rest of World Hospital Acquired Urinary Tract Infection Breakdown Data by Type
    • 9.3 Rest of World Hospital Acquired Urinary Tract Infection Breakdown Data by Application
    • 9.4 Rest of World Hospital Acquired Urinary Tract Infection Breakdown Data by Countries
      • 9.4.1 Rest of World Hospital Acquired Urinary Tract Infection Sales by Countries
      • 9.4.2 Rest of World Hospital Acquired Urinary Tract Infection Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Advanced Sterilization Products
      • 10.1.1 Advanced Sterilization Products Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.1.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.1.5 Advanced Sterilization Products Recent Development
    • 10.2 Becton
      • 10.2.1 Becton Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.2.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.2.5 Becton Recent Development
    • 10.3 Dickinson and Company
      • 10.3.1 Dickinson and Company Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.3.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.3.5 Dickinson and Company Recent Development
    • 10.4 Steris Corporation
      • 10.4.1 Steris Corporation Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.4.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.4.5 Steris Corporation Recent Development
    • 10.5 Getinge Group
      • 10.5.1 Getinge Group Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.5.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.5.5 Getinge Group Recent Development
    • 10.6 Kimberly-Clark Corporation
      • 10.6.1 Kimberly-Clark Corporation Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.6.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.6.5 Kimberly-Clark Corporation Recent Development
    • 10.7 Cantel Medical
      • 10.7.1 Cantel Medical Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.7.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.7.5 Cantel Medical Recent Development
    • 10.8 Biomerieux
      • 10.8.1 Biomerieux Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.8.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.8.5 Biomerieux Recent Development
    • 10.9 Belimed
      • 10.9.1 Belimed Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.9.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.9.5 Belimed Recent Development
    • 10.10 3M Company
      • 10.10.1 3M Company Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Hospital Acquired Urinary Tract Infection
      • 10.10.4 Hospital Acquired Urinary Tract Infection Product Introduction
      • 10.10.5 3M Company Recent Development
    • 10.11 Sterigenics International
    • 10.12 Synergy Health
    • 10.13 PLC

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Hospital Acquired Urinary Tract Infection Sales Channels
      • 11.2.2 Hospital Acquired Urinary Tract Infection Distributors
    • 11.3 Hospital Acquired Urinary Tract Infection Customers

    12 Market Forecast

    • 12.1 Global Hospital Acquired Urinary Tract Infection Sales and Revenue Forecast 2019-2025
    • 12.2 Global Hospital Acquired Urinary Tract Infection Sales Forecast by Type
    • 12.3 Global Hospital Acquired Urinary Tract Infection Sales Forecast by Application
    • 12.4 Hospital Acquired Urinary Tract Infection Forecast by Regions
      • 12.4.1 Global Hospital Acquired Urinary Tract Infection Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Hospital Acquired Urinary Tract Infection Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Hospital acquired urinary tract infections are caused by patients urethral catheters or invasive manipulation in the urogenital tract, which allows microbes to enter into the bladder and encourages proliferation by providing a sustainable environment.
      They are accountable for over 50% of infections.
      An array of tests can uncover type of infection and pathogen associated with the infection to efficiently treat the infected area.
      Increase in prevalence of hospital acquired UTIs and technological advancement in testing devices drive the market.
      In 2019, the market size of Hospital Acquired Urinary Tract Infection is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hospital Acquired Urinary Tract Infection.

      This report studies the global market size of Hospital Acquired Urinary Tract Infection, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Hospital Acquired Urinary Tract Infection sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Advanced Sterilization Products
      Becton
      Dickinson and Company
      Steris Corporation
      Getinge Group
      Kimberly-Clark Corporation
      Cantel Medical
      Biomerieux
      Belimed
      3M Company
      Sterigenics International
      Synergy Health
      PLC

      Market Segment by Product Type
      Microbial Testing Instruments
      Reagents and Consumables
      Infection Prevention and Surveillance Software

      Market Segment by Application
      Disease Testing
      Drug-resistance Testing

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Hospital Acquired Urinary Tract Infection status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Hospital Acquired Urinary Tract Infection manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Hospital Acquired Urinary Tract Infection are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now